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INTRODUCTION 
A prescription is a written advice that mentions drugs and 
other instructions given to either pharmacist or chemist to 
dispense the drugs to patients for the proper treatment of 
disease. It provides information like an adequate dose of the 
drug to be given, its duration and the way it has to be 
taken1,2. Diabetes mellitus is a chronic metabolic condition 
and requires treatment for long time/life long. It has been 
seen that diabetic patients also have other co-morbid 
conditions/complications like Hypertension, CAD, 
dyslipidemia, neuropathy, nephropathy etc3. The prevalence 
of this disease across the world was estimated to be 2.8% in 
2000 and 4.4 % in 2030.The number of people affected with 
diabetes is projected to increase from 172 million in 2000 to 
366 million in 20304,5. It is important to treat the diabetic 
patients wiselyto keep in mind all these co-morbid 
conditions too. In diabetes, the complications can be 
prevented only if the patient maintains strict glycaemic 
control3. Carrying out a drug utilisation study can provide 
valuable information to the researchers, policy makers and 
the drug and therapeutics committee members to determine 
the drug use pattern6,7. During our literature review, we 
found that a few studies have been conducted in South Asia. 
Hence, the present study was designed to keep in mind the 
diabetic patients who took treatment for long time and to 
asses the type of drugs used by the physicians and cost 
analysis of the prescriptions. 
Rational use of drugs for the treatment of a disease is of 
utmost importance for the well being of patients6. A doctor 
must treat the patient and not only a disease for the well 
being of patient. It will help in reducing the patient’s 
expenditure, lower adverse drug reaction, drug interactions 
and extra burden on medical as well as paramedical staff6,7. 
WHO has given a list of prescribing indicators to analyze the 
drugs prescribing pattern and the cost of a prescription7.The 
current study has been taken up to evaluate the drugs 
prescribing pattern along with demographic profile among 
diabetic patients in tertiary care teaching institute at 
Faridkot. 
MATERIALS AND METHODS: 
Prescriptions were randomly collected from the OPDs 
(outdoor patients’ departments) of Guru Gobind Singh 
Hospital, attached to Guru Gobind Singh-Medical College, 
Faridkot, over a period of six months. Prescriptions slips 
were taken from the patients after taking the written consent 
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and the relevant information was entered into the pretested 
proforma and analyzed fordemographic details of the 
patients andother parameters of Prescribing Indicators (as 
per the WHO guidelines) as follows: 
I. Demographic details of the Patients:  
a. Average age of the patients 
b. Sex (male and female ratio) 
c. Co-morbid conditions prevalent in diabetic patients 
II. To study the pattern of drug prescribing among 
diabetic outpatients 
III. To analyse the prescription as per the WHO 
Prescribing Indicators7: The following are the 
parameters: 
1. Average number of drugs per prescription 
(encounter) 
2. Percentage of drugs prescribed by generic name 
3. Percentage of prescriptions with an antibiotic 
prescribed 
4. Percentage of prescriptions with an injection 
prescribed 
5. Percentage of drugs prescribed from an Essential 
Medicine List 
6. Average drug cost per prescription or encounter 
This study was approved by the Institutional ethical 
committee (IEC). 
Inclusion criteria: 
Diabetic patients visiting the OPDs (out patient doors) of the 
hospital and patients who gave written informed consent to 
analyze their prescription after photocopy. 
Exclusion criteria: patients who are admitted in the ward, 
pregnancy induced diabetes mellitus and paediatric diabetic 
patients, patients who have surgery of pancreas 
(pancreatectomy) and recently got operation for any other 
surgery. 
RESULTS: 
I. Demography details 
A total of 366 prescriptions were collected that contained 
1824 drugs. Therewere patients of type 2 (n=360) and Type 
1 diabetes mellitus (n=06). Among type 2 diabetes patients 
Males and females were 48.34% and 51.66% respectively 
(Table I). Among these patients, the greatest number were in 
the age group of 60–69 years, followed by 50–59 years, 40–
49 years, 30-39 years and more than 70 years 
respectively(Table I). The mean +SD age of the patients was 
56.9 +12.55 years. 
It has been seen that 78.68% patients of diabetes mellitus 
have co-morbid conditions like cardiovascular diseases (HT, 
CAD, stroke and peripheral vascular disease), dyslipidemia, 
GIT, diabetic foot, asthma, nephropathy etc (Table II). 
Table I: Distribution of patients according to Age and Sex 
Age Male (n) % age Female (n) % age Total (n) % age 
30-39 12 6.89 10 5.37 22 5.8 
40-49 39 22.41 36 19.35 74 20.55 
50-59 66 37.94 54 29.03 120 33.35 
60-69 45 25.86 81 43.54 126 35 
>70 12 6.89 5 2.68 18 4.4 
Total 174 100 186 100 360 100 
Type 1 DM 6      
<30  6 100% 4 66.67 2 33.33 
 
Table II: Co-morbid Conditions Prevalent in Type 2 Diabetic patients 
Other Diseases N Percentage  
DM+HT 117 40.63 
DM+CAD 18 6.25 
DM+HT+ CVA 3 1.041 
DM+HT+CAD 9 3.125 
Total DM + CVDs 147 51.04 
Dyslipidemia 111 38.54 
Asthma 12 4.166 
Diabetic foot 9 3.125 
GIT disorders 6 2.083 
Nephropathy 2 0.694 
Ostioarthritis 1 0.347 
Total  288 100% 
DM- Type 2 Diabetes Mellitus, HT-Hypertension, CAD-Coronary artery disease, CVA- 
Cardiovascular accident, CVDs- Cardiovascular diseases 
 
Raj Kumar et al                                Journal of Drug Delivery & Therapeutics; 2013, 3(2), 56-61   58 
© 2011, JDDT. All Rights Reserved                                                        ISSN: 2250-1177                                                     CODEN (USA): JDDTAO 
II. Drugs prescribed from different groupsamong 
diabetic patients 
It has been observed that 28.45% of the drugs belong to 
antidiabetic groups (oral hypoglycaemic and insulin) while 
71.55% belong to other groups.Among oral antidiabetic 
drugs 85.6 % of the drugs prescribed as monotherapy and 
combination therapy was 14.4% either two drugs or three 
drugs (10.4% and 4% respectively). Insulin is prescribed in 
7.8% cases (Table III). 
 
Table III: Antidiabetic Drugs Used in Diabetic Patients 
Classification of Antidiabetic   N % age  
Total Drugs used for Diabetes mellitus 519 28.45% 
A. Oral Antidiabetic Agents 375 20.55 % age 
Name of Monotherapy 321 85.6% 
Glimepride 138 36.8% 
Gliclazide 18 4.8% 
Metformin 114 31.4% 
Pioglitazone 30 8% 
Voglibose 15 4% 
Vildagliptin 06 1.6% 
Combination Therapy- Oral 54 14.4% 
Glimepride+Metformin 24 6.4% 
Gliclazide+Metformin 12 3.2% 
Pioglitazone+Metformin 3 0.8% 
Glimepride+Metformin+Pioglitazone 15 4% 
B. Injectable Insulin 144 7.8% 
 
Table IV: Other Drugs Commonly Used in Diabetic Patients 
Drug’s Group N Percentage Remarks 
A. CVS 492 26.97 Out of Total Drugs 
1. RAAS 204 41.46 Out of Total  CVS drugs 
ACEI 90 18.29 Out of Total  CVS drugs 
Ramipril 
Enalapril 
78 
12 
15.85 
2.44 
Out of Total  CVS drugs 
ARB 114 23.17 Out of Total  CVS drugs 
Telmisertan 
Olmesertan 
Losartan 
75 
36 
3 
15.24 
7.32 
0.61 
Out of Total  CVS drugs 
 
2. Diuretics 90 18.29 Out of Total  CVS drugs 
Hydrochlorothiazide 
Torsemide 
Furosemide 
51 
27 
12 
10.36 
5.49 
2.44 
(used in combination with ACE and ARB) 
3. Beta blockers 48 9.75 Out of Total  CVS drugs 
 Metoprolol 
Atenolol 
21 
21 
4.26 
4.26 
Out of Total  CVS drugs 
4. Alpha blockers 6 1.21 Out of Total  CVS drugs 
5. CCBs 36 7.32 Out of Total  CVS drugs 
6. Nitrate 39 7.92 Out of Total  CVS drugs 
Antiplatelet  75 15.24 Out of Total  CVS drugs 
Aspirin  
Clopidogrel 
66 
9 
13.41 
1.83 
 
B. Lipid Lowering 111 5.86 Out of Total Drugs 
Atorvastatin (A) 60 54.05 Out of Total  lipid lowering agents 
Rosuvastatin (R) 12 10.81  
A +Fenofibrate 
R+ Fenofibrate  
 24 
15 
21.62 
13.51 
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CVS related drugswere prescribed in 26.97% and majority of 
them belong to antihypertensive group (77.34%), Diuretics 
18.29% and 15.24% antiplatlets respectively (Table IV). 
Multivitamins and minerals were prescribed in 22.20% 
(n=405) and commonly prescribed were B-complex (n= 284, 
42.96%)(Chart I). Methylcobalamine along with 
other(pargablin and gabapentin) were 34.07%. Vitamine D 
(n=72, 17.77%), Ca (n=24, 5.92%), Vit E (n= 6, 1.72%) and 
iron (n=12, 2.96%) were also prescribed in diabetic patients. 
Lipid lowering drugs were share 5.86% and commonly 
prescribed drugs were Atorvastatin, Rosuvastatin and 
combination of these drugs with Fenofibrate was 
35.13%(Table IV and Chart I). 
GIT related drugs prescribed by 6.57% (n=120) (Chart 1) 
cases and commonly prescribed were PPIs [(n=93, 77.5%, 
pantprazole (n=45, 37.5%),rabeprazole (n=42, 35%) and 
omeprazole (n=6, 5%)]. Other drugs used were rantidine 
(n=6, 5%), prokinetics (n=21, 12.5%), domperidone (n=21, 
17.5%), itapride (n=6, 5%) and laxative (n=6, 5%). 
Antimicrobials were prescribed by 5.75% (n=105) and 
commonly prescribed was Beta Lactam group 60% (n= 45) 
[Cephalosporin (n= 27, 25.71%), Penicillin (n=18 17.14%) 
and combination of beta lactam with pencillinase inhibitors 
(n= 18, 17.14%)] and metronidazole 18.14% (n= 18), 
macrolide 11.42% (n= 12), Flouroquinolone5.71% (n=6) and 
others groups were 5.71% ( n=6). 
CNS related drugs were prescribed by 2.19% (n=40), and 
benzodiazepines (chlorodizepoxide and clonazepam) 
commonly prescribed as compared to other CNS related 
drugs. 
NSAIDs were prescribed by 1.48% (n= 27) and Non-
selective COX inhibitors (Diclofenac, Paracetamol, etc) 
were commonly prescribed than selective COX inhibitors
 
 
 
 
III. Prescribing Indicators: 
It has been observed that average number of drugs 
prescribed per prescription was 4.98. Prescription with single 
drug (n=9, 2.4%), two drugs (n=12, 3.2%) and three drugs 
(n=18, 4.9%) were prescribed very less, while four (n=66) 
and more than four (n=261) drugs were prescribed by 
89.24% (n=1628 ). All (100 %) the drugs were written with 
trade (non-generic) names, while none of the drugs was 
mentioned with their generic name. 
Drugs from WHO- EML (Essential Medicine list’s) drugs 
are prescribed by 27.41% while from Indian EML contains 
31.36%, most of these drugs belong to oral antidiabetics, 
insulin, vitamins and minerals, CVS, antimicrobial agents, 
bronchodilator and NSAIDs. 
Oral forms prescribed were 85.85% and injectable were 
14.15% (insulin 7.8 %, n=144 and other injectable 6.35%, 
n=115).
 
Table V: Prescribing Indicators 
Parameter N  
Average number of drugs per prescription - 4.98 
Number of encounters with an injectable preparation prescribed 188 10.36% 
Number of fixed dose combinations prescribed 306 16.77% 
Number of drugs prescribed form EML of India 572 31.36% 
Number of drugs prescribed form EML of WHO 500 27.41% 
Number of encounters with an antibiotics prescribed 104 5.75% 
Number of drugs prescribed by generic name Nil Nil 
Antidiabetic
29%
CVS
27%
Vitamins and 
minerals
22%
GIT
7%
Antimicrobial
6%
Lipid lowering
6%
others
3%
Chart I: Percentage of Different Groups of Drugs
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The average cost of the oral antidiabetic agent per day per 
prescription was ₹7.95/- and₹ 8.28/- for injection Insulin. 
This cost increased to ₹10.15 with addition of CVS related 
drugs, ₹17.23/- with multivitamins and ₹ 10.57/- with lipid 
lowering agents and it was seen that if a patient was 
prescribed all these drugs then the average cost of the 
treatment got raised to ₹ 45/- or $ 0.82 USD (approx. with 
Oral antidiabetic) and ₹ 46/- or $ 0.83 USD (approx. with 
Injection insulin) per day per prescription. 
DISCUSSION: 
I. Demography details:  
The incidence of diabetic mellitus is slightly less in 
malesthan females(Table I) which is contrast to as observed 
in Updhayay DK et al (56.59% vs. 43.41%)8 which show 
higher incidence among male. 
Patients in the age group of 50–69 years have more 
incidence of diabetes mellitus than the other age group, this 
incidence is more as observed in the other study [Updhayay 
DK et al (59.89%)]
8
, followed by, 40–49 years and less than 
30-39 years and more than 70 years (Table I). The mean 
+SD age of the patients is 56.9 +12.55 years.  
It has been seen that 78.68% patients of diabetes mellitus 
have co-morbid conditions (like cardiovascular diseases 
(HT, CAD, stroke and peripheral vascular disease), 
dyslipidemia, GIT, diabetic foot, asthma, nephropathy etc) 
(Table I) which is higher than as observed in Updhayay DK 
et al (70.33%)8. Co-morbidconditions like CVDs and 
nephropathy is less while asthma is more as observed by 
Updhayay DK (76.42%, 1.13% and 1.13% respectively)8.  It 
has been observed that Dyslipidemia, diabetic foot and GIT 
disordersare also present in diabetes patients of this region as 
compared to study done by UpdhayayDK et al8. 
 
II. Prescriber indicators: 
In this study, average number of drugs prescribed is more as 
compared to Upadhyay DK et al  (3.76 per prescription)8 and 
Enwere et al (4.0 per prescription )9studies. 
Maximum number of drugs prescribed is nine (4.1%).   
Sixdrugs(25.4%) are prescribed more frequently as 
compared to other study (four drugs, 21.98%)8.Four and 
more than four drugs are prescribed (89.5 %) more as 
observed in other study (52.75%)8.It is observed that single 
drug (2.4%), two drugs (3.2%) and three drugs (4.9 %) 
prescribed are less as comparedto other study (6.59%, 
21.43%  and 19.23% respectively)8indicating that more than 
three drugsprescribed is frequently used to treat a disease 
which is a cause of concern may be due to other co-morbid 
conditions in diabetes patients. 
It has been observed that 28.35% of the drugs belong to 
antidiabetic groups (oral hypoglycaemic and insulin) while 
71.65% belong to other groups. Oralantidiabetic drugs are 
used more than Updhayay DK et al (65%)8. While 
monotherapyused for treatment is more than as observed in 
Updhayay et al (58.34%)8 and combination therapy is used 
less(Table III). Monotherapy with sulfonylurea and 
pioglitazone are used more while metformin is less as 
compared to UpdhayayDK et al (35.35%, 4.78% and 51.27% 
respectively)8. Combinationtherapy is used two drugs and 
three drugs, frequently used dual therapy are glimepride with 
metformin (6.4%), gliclazide with metformin (3.2%)and 
three drugs (glimepride with metformin and pioglitazone) 
(4.1%)(Table III) that less is prescribed  as seen in Dhwani 
K et al (8.7%, 5.5% and 7.9% respectively)10. Injectable 
Insulin (7.8%) also prescribed less as compared to Dhwani K 
et al (35%) study10. 
CVS related drugs were prescribed in 26.97%and majority of 
them belong to antihypertensive group 77.34%. CVS drugs 
prescribed is less as observed in UpdhayayDK et al 
(35.91%)8.It have been seen that antihypertensive drugs like 
RAAS related drugs, CCB and antiplatlets are prescribed 
less while diuretics is more as observed in Enwere OO et al 
(53%, 36.7%, 56.4% and 18.29% respectively) study9. 
Lipid lowering drugsshare 6.08% which are slightly more 
than Enware OO et al (5.5%)9and commonly prescribed 
drugs are Atorvastatin, Rosuvastatin and combination of 
both these drugs with Fenofibrate.It   has been seen that 
Vitamins and mineralsand antimicrobials are prescribed 
more as explored by the Upadhayay DK et al (2.92% and 
0.88%)
8
. 
Injectable medicines are prescribed by 14.15% cases which 
are very less as observed by Updhyay et al (15.38%)8 and 
Enwere et al (26.4%)9. 
It has been observed that Drugs from WHO-EML11 and 
Indian EML12 are prescribed (Table V) very less as observed 
by UpdhayayDK et al (40.20% and 54.1%)8, most of these 
drugs belong to oral antidiabetics, insulin, vitamins and 
minerals, CVS, antimicrobials and NSAIDs.Fixed dose 
combination share 16.77% that is more than UpdhayayDK  
et al (2.34%)8. 
Drug consumption and Cost analysis: 
The average cost per prescription is ₹ 26.67/- or $ 0.49 USD 
that is less as observed inUpdhayaDK et al ($ 16.17)8and 
Enware OO ($1.42)9. 
The average cost of the oral antidiabetic agent per day per 
prescription is ₹7.95/- and ₹ 8.28/- for injection insulin. 
This cost increased to ₹ 10.15/- with addition of CVS 
related drugs, ₹ 17.23/- with multivitamins and ₹ 10.57/- 
with lipid lowering agents and it was seen that if a patient 
was prescribed all these drugs then the average cost of the 
treatment got raised to ₹ 45/- or $0.82 USD (approx. with 
Oral antidiabetic) and ₹ 46/- or 0.83 USD (approx. with 
Injection insulin) per day per prescription. (1USD= 55 INR) 
IMPLICATIONS OF THIS STUDY 
Diabetes mellitus is a chronic metabolic condition and 
patients require long treatment.  This study was done in 
North India in Malwa region of Punjab.This is an 
agricultural land and people have traditional diet habits, style 
of living.By doing this study, we have seen that dyslipidemia 
is frequently present in diabetic patients as compared to 
other studies which is the cause of concern. By this study,we 
get an idea about the co-morbid condition present in diabetic 
patients in this part of India. By use of this kind of data we 
can treat the patients rationally and advice the patient for 
proper treatment, improve the adherence to therapy and 
reduce the cost of treatment. Thus, this study has provided a 
baseline data regarding the prescribing pattern in diabetes 
patients. Since diabetes is a common problem in South Asia 
and prescription cost is one of the major reasons for non-
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adherence to drug therapy, there is a need to prescribe 
cheaperalternatives for these patients. This study also 
provides a scope for further research in this area. 
LIMITATIONS 
Our study had a few limitations. The diabetes patients 
admitted in the hospital were not included in the study. The 
diabetic patients who underwent surgery recently and 
paediatric diabetic patients and pregnancy induced patients 
were also excluded. Moreover, our study was done for a 
short period of time and the number of patients studied was 
low. Hence, similar studies covering large number of 
patients are needed to confirm our findings. 
CONCLUSION:  
Most of diabetic patients have co-morbid conditions; 
therefore, they require more than one medication for their 
proper treatment. Thereis a high tendency and frequency to 
prescribe more than two drugs but less prescribed from the 
Essential Medicine List. Most of the drugs prescribed 
aregenerally cardiovascular related drugs and vitamins 
combined with oral antidiabetic drugs. There is an urgent 
need to develop the prescription writing skills for budding 
doctors regarding the use of Essential Medicine List to 
reduce the cost of treatment and better compliance of the 
patients.
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